RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00059887.xml
CC BY 4.0 · Brazilian Journal of Oncology 2025; 21
DOI: 10.1055/s-0045-1807769
DOI: 10.1055/s-0045-1807769
BREAST TUMORS
1958
POSTER PRESENTATION
Effect of trastuzumab interchangeability on efficacy and safety outcomes in women with early-stage HER2-positive breast cancer
Authors
Publikationsverlauf
Artikel online veröffentlicht:
06. Mai 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Bibliographical Record
Mário Jorge Sobreira da Silva, Ludmila Andrade Alves Ferreira, Anke Bergmann, Patrícia Ribeiro Portela de Araujo, Maely Peçanha Fávero Retto. Effect of trastuzumab interchangeability on efficacy and safety outcomes in women with early-stage HER2-positive breast cancer. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807769
Mário Jorge Sobreira da Silva, Ludmila Andrade Alves Ferreira, Anke Bergmann, Patrícia Ribeiro Portela de Araujo, Maely Peçanha Fávero Retto. Effect of trastuzumab interchangeability on efficacy and safety outcomes in women with early-stage HER2-positive breast cancer. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807769